Skip to Content

Auvi-Q Approval History

FDA Approved: Yes (First approved August 10, 2012)
Brand name: Auvi-Q
Generic name: epinephrine
Dosage form: Injection
Company: Sanofi
Treatment for: Anaphylaxis, Allergic Reactions

Auvi-Q (epinephrine injection) is a voice-guided epinephrine auto-injector for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis.

Development History and FDA Approval Process for Auvi-Q

DateArticle
Nov 20, 2017Approval FDA Approves Kaléo’s Auvi-Q (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children
Aug 13, 2012Approval Sanofi Announces FDA Approval for Auvi-Q, First Voice-guided Epinephrine Auto-injector for Patients with Life-threatening Allergies

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide